{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:02:41Z","timestamp":1786460561324,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:title>EXECUTIVE SUMMARY<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Global cerebral ischemia occurs due to reduced blood supply to the brain. This is commonly caused by a cessation of myocardial activity associated with cardiac arrest and cardiac surgery. Survival is not the only important outcome because neurological dysfunction impacts on quality of life, reducing independent living. Magnesium has been identified as a potential neuroprotective agent; however, its role in this context is not yet clear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The objective of this review was to present the best currently available evidence related to the neuroprotective effects of magnesium during a period of global cerebral ischemia in adults with cardiac arrest or cardiac surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Inclusion criteria Types of participants<\/jats:title>\n                    <jats:p>The current review considered adults aged over 18 years who were at risk of global cerebral ischemia associated with cardiac arrest or cardiac surgery. Studies of patients with existing neurological deficits or under the age of 18 years were excluded from the review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Types of intervention(s)\/phenomena of interest<\/jats:title>\n                    <jats:p>The intervention of interest was magnesium administered in doses of at least of 2 g compared to placebo to adult patients within 24 hours of cardiac arrest or cardiac surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Types of studies<\/jats:title>\n                    <jats:p>The current review considered experimental designs including randomized controlled trials, non-randomized controlled trials and quasi-experimental designs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>The outcome of interest were neurological recovery post-cardiac arrest or cardiac surgery, as measured by objective scales, such as but not limited to, cerebral performance category, brain stem reflexes, Glasgow Coma Score and independent living or dependent living status. To enable assessment of the available data, neuroprotection was examined by breaking down neurological outcomes into three domains \u2013 functional neurological outcomes, neurophysiological outcomes and neuropsychological outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Search strategy<\/jats:title>\n                    <jats:p>The search strategy aimed to find both published and unpublished studies between January 1980 and August 2014, utilizing the Joanna Briggs Institute (JBI) three-step search strategy. Databases searched included PubMed, Embase, CINAHL, Cochrane Central Register of Controlled Trials, Australian Clinical Trials Register, Australian and New Zealand Clinical Trials Register, Clinical Trials, European Clinical Trials Register and ISRCTN Registry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodological quality<\/jats:title>\n                    <jats:p>The studies included in this review were of moderate-to-good-quality randomized controlled trials. Studies included measured neurological outcome using functional neurological assessment, neuropsychiatric assessment or neurophysiological assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction<\/jats:title>\n                    <jats:p>Data were extracted using standardized templates provided by the JBI Meta-analysis of Statistics Assessment and Review Instrument software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data synthesis<\/jats:title>\n                    <jats:p>Quantitative data were, where possible, pooled in statistical meta-analysis using Review Manager 5.3 (The Nordic Cochrane Centre, Cochrane; Copenhagen, Denmark). Where statistical pooling was not possible, the findings were presented in narrative form, including tables and figures, to aid in data presentation, where appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven studies with a total of 1164 participants were included in this review. Neurological outcome was categorized into three domains: functional neurological, neurophysiological and neuropsychological outcomes. Meta-analysis of three studies assessing the neuroprotective properties of magnesium administration post cardiac arrest found improved functional neurological outcome (odds ratio 0.44; 95% confidence interval 0.24-0.81).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Magnesium may improve functional neurological outcome in patients who suffer global cerebral ischemia associated with cardiac surgery and cardiac arrest. Magnesium does not decrease neuropsychological decline.<\/jats:p>\n                    <jats:p>Further testing of neurological outcomes in the domains of functional outcomes, neurophysiological markers and neuropsychological tests are required to further understanding of the neuroprotective effects of magnesium. Suitable dosing regimens should be investigated prior to introduction into clinical practice. Further research is required to investigate the optimal magnesium dose.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.11124\/jbisrir-2016-003236","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T16:58:34Z","timestamp":1484326714000},"page":"86-118","source":"Crossref","is-referenced-by-count":13,"title":["The use of therapeutic magnesium for neuroprotection during global cerebral ischemia associated with cardiac arrest and cardiac surgery in adults: a systematic review"],"prefix":"10.11124","volume":"15","author":[{"given":"Anna","family":"Pearce","sequence":"first","affiliation":[{"name":"Joanna Briggs Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Lockwood","sequence":"additional","affiliation":[{"name":"Joanna Briggs Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"van den Heuvel","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Pearce","sequence":"additional","affiliation":[{"name":"Joanna Briggs Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia"},{"name":"School of Nursing, Midwifery and Paramedicine, Australian Catholic University, Canberra, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"R1-20230825","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.resuscitation.2004.09.008","article-title":"Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries. A statement for healthcare professionals from a task force of the international liaison committee on resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa)","volume":"63","author":"Jacobs","year":"2004","journal-title":"Resuscitation"},{"issue":"4","key":"R2-20230825","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ienj.2009.01.001","article-title":"Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication: a scientific statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anaesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke (Part 1)","volume":"17","author":"Nolan","year":"2009","journal-title":"Int Emerg Nurs"},{"issue":"9407","key":"R3-20230825","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(04)15490-1","article-title":"Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial","volume":"363","author":"Muir","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"R4-20230825","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0300-9572(01)00408-7","article-title":"Outcomes of out-of-hospital cardiac arrest patients in Perth, Western Australia, 1996-1999","volume":"51","author":"Finn","year":"2001","journal-title":"Resuscitation"},{"issue":"3","key":"R5-20230825","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4037\/ajcc2007.16.3.240","article-title":"Improving survival after in-hospital cardiac arrest: the Australian experience","volume":"16","author":"Peters","year":"2007","journal-title":"Am J Crit Care"},{"issue":"9087","key":"R6-20230825","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(97)05048-4","article-title":"Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff","volume":"350","author":"Thel","year":"1997","journal-title":"Lancet"},{"issue":"13","key":"R7-20230825","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.110.988725","article-title":"Post cardiac arrest syndrome: a review of therapeutic strategies","volume":"123","author":"Stub","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"R8-20230825","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ncl.2008.03.015","article-title":"Management of brain injury after resuscitation from cardiac arrest","volume":"26","author":"Geocadin","year":"2008","journal-title":"Neurol Clin"},{"issue":"4","key":"R9-20230825","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.0889-7204.2001.00615.x","article-title":"The natural history of recovery following sudden cardiac arrest and internal cardioverter-defibrillator implantation","volume":"16","author":"Dougherty","year":"2001","journal-title":"Prog Cardiovasc Nurs"},{"issue":"4","key":"R10-20230825","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jtcvs.2005.11.018","article-title":"Magnesium as a neuroprotectant in cardiac surgery: a randomized clinical trial","volume":"131","author":"Bhudia","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"R11-20230825","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0300-9572(02)00203-4","article-title":"Quality of life 6-months after cardiac arrest","volume":"55","author":"Granja","year":"2002","journal-title":"Resuscitation"},{"issue":"3","key":"R12-20230825","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1684\/mrh.2013.0345","article-title":"The neuroprotective effect of magnesium sulphate during iatrogenically-induced ventricular fibrillation","volume":"26","author":"Rinosl","year":"2013","journal-title":"Magnes Res"},{"key":"R13-20230825","article-title":"Weaning from cardiopulmonary bypass (CPB)","author":"Fitzsimons","year":"2015"},{"issue":"12","key":"R14-20230825","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1161\/STROKEAHA.113.002703","article-title":"Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery","volume":"44","author":"Mathew","year":"2013","journal-title":"Stroke"},{"key":"R16-20230825","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/UPO9780987073051.004","article-title":"Magnesium transport across the blood-brain barriers","author":"Ghabriel","year":"2011","journal-title":"Magnesium in the central nervous system"},{"key":"R17-20230825","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1017\/UPO9780987073051.005","article-title":"Intracellular free Mg2+ and MgATP2\u2212 in cooridinate control of protein synthesis and cell proliferation","author":"Rubin","year":"2011","journal-title":"Magnesium in the central nervous system"},{"issue":"4","key":"R18-20230825","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/01.STR.0000259628.94421.09","article-title":"Magnesium for treatment of acute lacunar stroke syndromes: further analysis of the IMAGES trial","volume":"38","author":"Aslanyan","year":"2007","journal-title":"Stroke"},{"issue":"925","key":"R19-20230825","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/pmj.78.925.641","article-title":"Magnesium in stroke treatment","volume":"78","author":"Muir","year":"2002","journal-title":"Postgrad Med J"},{"issue":"4","key":"R20-20230825","first-page":"339","article-title":"Cerebral protective effect of magnesium during CABG assessed by cerebral oximetry and cognitive P300 visual evoked potentials","volume":"8","author":"Hafez","year":"2013","journal-title":"World J Med Sci"},{"issue":"3","key":"R21-20230825","doi-asserted-by":"crossref","first-page":"158S","DOI":"10.1684\/mrh.2009.0175","article-title":"Magnesium in acute and chronic brain injury: an update","volume":"22","author":"Vink","year":"2009","journal-title":"Magnes Res"},{"key":"R22-20230825","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1017\/UPO9780987073051.016","article-title":"Magnesium in clinical stroke","author":"Saver","year":"2011","journal-title":"Magnesium in the central nervous system"},{"issue":"5","key":"R23-20230825","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1161\/01.STR.0000124458.98123.52","article-title":"Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial","volume":"35","author":"Saver","year":"2004","journal-title":"Stroke"},{"issue":"4","key":"R24-20230825","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00008506-199710000-00006","article-title":"Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients","volume":"9","author":"Fuchs-Buder","year":"1997","journal-title":"J Neurosurg Anesthesiol"},{"key":"R25-20230825","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009302.pub2","article-title":"Different regimens for neuroprotection of the foetus for women at risk of preterm birth (Review)","author":"Bain","year":"2012","journal-title":"Cochrane Database Sys Rev"},{"key":"R26-20230825","first-page":"1","article-title":"Magnesium sulphate for term infants following perinatal asphyxia","author":"Kent","year":"2009","journal-title":"Cochrane Database Sys Rev"},{"issue":"9321","key":"R27-20230825","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"Trial","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"R28-20230825","first-page":"588","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"R29-20230825","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010909","article-title":"Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department","author":"Kew","year":"2014","journal-title":"Cochrane Database Sys Rev"},{"key":"R30-20230825","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/UPO9780987073051.013","article-title":"The role of magnesium in traumatic brain injury","author":"Cook","year":"2011","journal-title":"Magnesium in the central nervous system"},{"key":"R31-20230825","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/UPO9780987073051.015","article-title":"Magnesium in subarachnoid hemorrhage","author":"van den Bergh","year":"2011","journal-title":"Magnesium in the central nervous system"},{"issue":"3","key":"R32-20230825","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0300-9572(97)00062-2","article-title":"Magnesium in cardiac arrest (the magic trial)","volume":"35","author":"Fatovich","year":"1997","journal-title":"Resuscitation"},{"issue":"4","key":"R33-20230825","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1212\/WNL.59.4.506","article-title":"Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest","volume":"59","author":"Longstreth","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"R34-20230825","doi-asserted-by":"crossref","first-page":"3","DOI":"10.11124\/01938924-201513040-00002","article-title":"The use of therapeutic magnesium for neuroprotection during global cerebral ischemia associated with cardiac arrest and cardiac bypass surgery in adults: a systematic review protocol","volume":"13","author":"Pearce","year":"2015","journal-title":"JBI Database System Rev Implement Rep"},{"issue":"5","key":"R35-20230825","first-page":"693","article-title":"The effect of intravenous magnesium sulfate on serum levels of N-terminal pro-brain natriuretic peptide (NT pro-BNP) in elective CABG with cardiopulmonary bypass","volume":"27","author":"Dabbagh","year":"2013","journal-title":"J Anesthesiol"},{"issue":"9","key":"R36-20230825","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.hlc.2013.03.002","article-title":"Retrograde cardioplegia revisited: open technique for long aortic cross clamping","volume":"22","author":"Ito","year":"2013","journal-title":"Heart Lung Circ"},{"issue":"4","key":"R37-20230825","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1684\/mrh.2012.0324","article-title":"Does post-cardiac surgery magnesium supplementation improve outcome?","volume":"25","author":"Carrio","year":"2012","journal-title":"Magnes Res"},{"key":"R38-20230825","first-page":"S389","article-title":"Therapeutic hypothermia in seven-year-old patient with long QT syndrome and cardiac arrest","volume":"6","author":"Aktas","year":"2009","journal-title":"Heart Rhythm"},{"issue":"6","key":"R39-20230825","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1161\/STROKEAHA.108.542381","article-title":"In search of clinical neuroprotection after brain ischemia: the case for mild hypothermia (35 degrees C) and magnesium","volume":"40","author":"Meloni","year":"2009","journal-title":"Stroke"},{"key":"R40-20230825","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/WNL.60.11.1868","article-title":"Randomized clinical trial of magnesium, diazepam or both after out of hospital cardiac arrest, multiple letters","volume":"60","author":"Iandau","year":"2003","journal-title":"Neurology"},{"key":"R41-20230825","first-page":"227","volume":"10","author":"Mohseni","year":"2013","journal-title":"ARYA Atheroscler"},{"issue":"4","key":"R42-20230825","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Annals of internal medicine"},{"issue":"11","key":"R43-20230825","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/WNL.60.11.1868","article-title":"Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest [1] (multiple letters)","volume":"60","author":"Landau","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"R44-20230825","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1161\/STROKEAHA.113.004025","article-title":"Response to letter regarding article, \u201cIntraoperative magnesium administration does not improve neurocognitive function after cardiac surgery\u201d","volume":"45","author":"Mathew","year":"2014","journal-title":"Stroke"},{"issue":"(Suppl 1)","key":"R45-20230825","doi-asserted-by":"crossref","first-page":"i113","DOI":"10.1093\/bja\/aet059","article-title":"Pharmacological perioperative brain neuroprotection: a qualitative review of randomized clinical trials","volume":"110","author":"Bilotta","year":"2013","journal-title":"Br J Anaesth"},{"issue":"5","key":"R46-20230825","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ana.20481","article-title":"Neurocognitive complications after coronary artery bypass surgery","volume":"57","author":"Selnes","year":"2005","journal-title":"Ann Neurol"},{"issue":"1","key":"R47-20230825","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.mat.0000191334.51375.7e","article-title":"Neurocognitive function in patients with ventricular assisted devices","volume":"52","author":"Zimpfer","year":"2006","journal-title":"ASAIO J"},{"issue":"3","key":"R48-20230825","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1161\/STROKEAHA.113.004005","article-title":"Letter by Derakhshan regarding article, \u201cIntraoperative magnesium administration does not improve neurocognitive function following cardiac surgery\u201d","volume":"45","author":"Derakhshan","year":"2014","journal-title":"Stroke"},{"issue":"3","key":"R50-20230825","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0300-9572(00)00375-0","article-title":"Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting","volume":"49","author":"Allegra","year":"2001","journal-title":"Resuscitation"},{"issue":"6","key":"R51-20230825","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1056\/NEJMoa1408827","article-title":"Prehospital use of magnesium sulfate as neuroprotection in acute stroke","volume":"372","author":"Saver","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"R52-20230825","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/01.CIR.84.2.960","article-title":"Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council","volume":"84","author":"Cummins","year":"1991","journal-title":"Circulation"}],"container-title":["JBI Database of Systematic Reviews and Implementation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01938924-201701000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:56:46Z","timestamp":1786453006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01938924-201701000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.11124\/jbisrir-2016-003236","relation":{},"ISSN":["2202-4433"],"issn-type":[{"value":"2202-4433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}